| Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial Y Reznik, O Cohen, R Aronson, I Conget, S Runzis, J Castaneda, SW Lee The Lancet 384 (9950), 1265-1272, 2014 | 257 | 2014 |
| Real-world performance of the MiniMed™ 780G system: first report of outcomes from 4120 users JD Silva, G Lepore, T Battelino, A Arrieta, J Castañeda, B Grossman, ... Diabetes Technology & Therapeutics 24 (2), 113-119, 2022 | 155 | 2022 |
| Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study E Hommel, B Olsen, T Battelino, I Conget, I Schütz-Fuhrmann, R Hoogma, ... Acta diabetologica 51, 845-851, 2014 | 126 | 2014 |
| Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study K Nørgaard, A Scaramuzza, N Bratina, NM Lalić, P Jarosz-Chobot, ... Diabetes technology & therapeutics 15 (4), 273-280, 2013 | 126 | 2013 |
| Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial E Bosi, P Choudhary, HW De Valk, S Lablanche, J Castañeda, S De Portu, ... The lancet Diabetes & endocrinology 7 (6), 462-472, 2019 | 108 | 2019 |
| Comparison of MiniMed 780G system performance in users aged younger and older than 15 years: Evidence from 12 870 real‐world users A Arrieta, T Battelino, AE Scaramuzza, J Da Silva, J Castañeda, ... Diabetes, Obesity and Metabolism 24 (7), 1370-1379, 2022 | 92 | 2022 |
| Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study P Choudhary, R Kolassa, W Keuthage, J Kroeger, C Thivolet, M Evans, ... The lancet Diabetes & endocrinology 10 (10), 720-731, 2022 | 84 | 2022 |
| Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12‐month data from the OpT2mise randomized trial R Aronson, Y Reznik, I Conget, JA Castañeda, S Runzis, SW Lee, ... Diabetes, Obesity and Metabolism 18 (5), 500-507, 2016 | 73 | 2016 |
| Routine use of continuous glucose monitoring in 10 501 people with diabetes mellitus T Battelino, S Liabat, HJ Veeze, J Castaneda, A Arrieta, O Cohen Diabetic Medicine 32 (12), 1568-1574, 2015 | 72 | 2015 |
| Appraisal of several methods to model time to multiple events per subject: modelling time to hospitalizations and death J Castañeda, B Gerritse Revista Colombiana de Estadística 33 (1), 43-61, 2010 | 62 | 2010 |
| Predictors of time in target glucose range in real‐world users of the MiniMed 780G system J Castañeda, C Mathieu, HJ Aanstoot, A Arrieta, J Da Silva, J Shin, ... Diabetes, Obesity and Metabolism 24 (11), 2212-2221, 2022 | 55 | 2022 |
| Real‐world performance of the MiniMed™ 670G system in Europe J Da Silva, E Bosi, J Jendle, A Arrieta, J Castaneda, B Grossman, ... Diabetes, Obesity and Metabolism 23 (8), 1942-1949, 2021 | 43 | 2021 |
| The impact of insulin pump therapy on glycemic profiles in patients with type 2 diabetes: data from the OpT2mise study I Conget, J Castaneda, G Petrovski, B Guerci, AS Racault, Y Reznik, ... Diabetes Technology & Therapeutics 18 (1), 22-28, 2016 | 43 | 2016 |
| Evaluation of circulating intestinally committed memory B cells in children vaccinated with attenuated human rotavirus vaccine OL Rojas, L Caicedo, C Guzmán, LS Rodríguez, J Castañeda, L Uribe, ... Viral Immunology 20 (2), 300-311, 2007 | 40 | 2007 |
| A Look at Confidence Intervals in Research JA Castañeda, J Fabián Gil Revista Colombiana de Psiquiatría 33 (2), 193-201, 2004 | 38* | 2004 |
| The SWITCH Study (Sensing With Insulin pump Therapy to Control HbA1c): Design and Methods of a Randomized Controlled Crossover Trial on Sensor … I Conget, T Battelino, M Giménez, H Gough, J Castaneda, J Bolinder Diabetes technology & therapeutics 13 (1), 49-54, 2011 | 33 | 2011 |
| Una mirada al valor de p en investigación JF Gil, JA Castañeda Revista Colombiana de psiquiatría 34 (3), 414-424, 2005 | 33 | 2005 |
| OpT2mise: a randomized controlled trial to compare insulin pump therapy with multiple daily injections in the treatment of type 2 diabetes—research design and methods R Aronson, O Cohen, I Conget, S Runzis, J Castaneda, S De Portu, S Lee, ... Diabetes technology & therapeutics 16 (7), 414-420, 2014 | 28 | 2014 |
| Complex assessment of metabolic effectiveness of insulin pump therapy in patients with type 2 diabetes beyond HbA1c reduction R Chlup, S Runzis, J Castaneda, SW Lee, X Nguyen, O Cohen Diabetes technology & therapeutics 20 (2), 153-159, 2018 | 27 | 2018 |
| Real‐world performance of the MiniMed 780G advanced hybrid closed loop system in Latin America: substantial improvement in glycaemic control with each technology iteration of … B Grassi, AM Gómez, LE Calliari, D Franco, M Raggio, F Riera, M Castro, ... Diabetes, Obesity and Metabolism 25 (6), 1688-1697, 2023 | 23 | 2023 |
